GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (XCNQ:PSYG) » Definitions » ROCE %

Psyence Group (XCNQ:PSYG) ROCE % : -206.50% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Psyence Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Psyence Group's annualized ROCE % for the quarter that ended in Dec. 2024 was -206.50%.


Psyence Group ROCE % Historical Data

The historical data trend for Psyence Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group ROCE % Chart

Psyence Group Annual Data
Trend Dec19 Dec20 Mar22 Mar23 Mar24
ROCE %
-23.46 -269.57 -334.23 -287.67 -

Psyence Group Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 775.82 - - - -206.50

Psyence Group ROCE % Calculation

Psyence Group's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=-69.373/( ( (4.001 - 2.622) + (3.272 - 15.073) )/ 2 )
=-69.373/( (1.379+-11.801)/ 2 )
=-69.373/-5.211
=1,331.28 %

Psyence Group's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=-12.048/( ( (4.173 - 3.349) + (11.944 - 1.099) )/ 2 )
=-12.048/( ( 0.824 + 10.845 )/ 2 )
=-12.048/5.8345
=-206.50 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Group  (XCNQ:PSYG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Psyence Group ROCE % Related Terms

Thank you for viewing the detailed overview of Psyence Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Group Business Description

Traded in Other Exchanges
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.
Executives
Jody Aufrichtig Director, Senior Officer
Warwick Corden-lloyd Senior Officer
Neil Maresky Senior Officer

Psyence Group Headlines

No Headlines